Navigation Links
Biocartis versterkt managementteam met commercieel directeur
Date:9/4/2013

LAUSANNE, Zwitserland en MECHELEN, België, September 4, 2013 /PRNewswire/ --


Biocartis, een bedrijf voor moleculaire diagnostiek, kondigt vandaag aan dat Ulrik Cordes werd aangesteld als Commercieel Directeur (CCO - Chief Commercial Officer). Ulrik Cordes heeft meer dan 18 jaar ervaring in verschillende marketing en sales posities in zowel de medtech-, farma- als biotechindustrie. De laatste 10 jaar vervulde hij topmanagement functies.

"We zijn verheugd dat Ulrik ons managementteam vervoegd," zegt Rudi Pauwels, CEO en voorzitter van de Raad van Bestuur van Biocartis. "Biocartis evolueerde de laatste jaren van een ontwikkelings- naar een commercieel bedrijf. Het aantrekken van Ulrik is een cruciale stap om ons vooropgestelde doel te bereiken: ervoor zorgen dat gepersonaliseerde geneeskunde een dagelijkse realiteit wordt door de uitbouw van een wereldwijde business. Ulrik beschikt over een unieke combinatie van ervaring en succes in het uitbouwen van geslaagde commerciële strategieën en het aantrekken van verkoopsprofessionals met wereldklasse."

Voordat Ulrik Cordes bij Biocartis begon, werkte hij voor Thermo Fisher Scientific als Global Sales & Marketing Director Slides & Specialty Glass en dat sinds maart 2012. Voorheen, sinds 2002, was Ulrik actief bij DAKO A/S - een wereldvermaard bedrijf in kankerdiagnostiek, waar hij een aantal functies met toenemende verantwoordelijkheid uitoefende, de meest recente als Vice President Marketing Operations en Vice President Asia Pacific & Export Region. Hij begon zijn carrière in 1995 bij Pharmacia Biotech A/S (nu onderdeel van GE Healthcare). Ulrik behaalde zijn Master of Science in Biochemie aan de Universiteit van Kopenhagen en een Commercieel Bachelor diploma (HD) aan de Business School van Kopenhagen.

Over Bioc
'/>"/>

SOURCE Biocartis NV
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Bausch + Lomb nomme Robert Bertolini président et directeur financier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 2014  As the Medical Affairs, role has become ... this area are exploring methods to develop strong capabilities ... Consortium at Best Practices, LLC is designed to give ... the key challenges they face. The consortium will provide ... virtual roundtable discussions where leaders discuss key findings from ...
(Date:8/22/2014)... Ohio , Aug. 22, 2014 MC Medical, ... Inc. (MID), a Columbus, OH medical ... distribute the FloShield laparoscopic and robotic visualization system in ... be approved for sale in Japan ... a long-time experience and an extensive product portfolio in endoscopic ...
(Date:8/22/2014)... Aug. 22, 2014  Research presented at the 29 th ... developed by Hera Therapeutics Inc. combats three types of human ... cervical cancer. When tested in several cultured human ... HPV-11 cells, according to Louise T. Chow , Ph.D. ... at the Seattle conference. The National ...
Breaking Medicine Technology:Best Practices' Medical Affairs Consortium Survey Has Achieved Strong Participation 2MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2
... KALAMAZOO, Mich., Sept. 9 Global Pharmaceutical Services ... the worldwide pharmaceutical and biotechnology industry announces a new clinical ... has entered into an exclusive partnership with Abridge Clinical Research ... India. "We are delighted in working with such an experienced ...
... , IRVINE, Calif., Sept. 8 ... U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ... ocular itching associated with allergic conjunctivitis in patients two years of ... new, safe and effective way to treat the itching caused by ...
Cached Medicine Technology:Life Sciences Company Opens Clinical Trial Bridge to India 2ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies 2ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies 3ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies 4ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies 5
(Date:8/22/2014)... Medicine team has found that targeted automated alerts ... infections in hospital patients with urinary catheters. In ... simplified, the rate of improvement dramatically increased. , ... need urinary catheters in the first place and ... catheters that have not been removed within a ...
(Date:8/22/2014)... (HealthDay News) -- Many Americans know little about how Ebola ... an outbreak in the United States, a new survey shows. ... that there will be a major Ebola outbreak in the ... immediate family member will get sick with the deadly virus ... of Public Health poll. However, those opinions don,t match ...
(Date:8/22/2014)... 22, 2014 Millennium Treatment Group, ... Lantana, FL, recently launched a new website. Patients, ... information can now find Millennium Treatment Group at ... went live at the beginning of July. Everything ... can be found on the website. There’s an ...
(Date:8/22/2014)... Las Vegas, NV (PRWEB) August 22, 2014 ... that teaches readers how they can use natural methods ... for years has caught the attention of Shane Michaels, ... only a condition that affects the skin, it can ... suffer from it,” reports Michaels. “The intense itching and ...
(Date:8/22/2014)... protein 11 (BIM) deletion in advanced non-small cell ... free survival (PFS) in epidermal growth factor receptor ... Asian patients. Also, BIM deletion independently predicts overall ... BIM protein can activate the programmed cell death ... BIM deletion has been detected in 12.8% of ...
Breaking Medicine News(10 mins):Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 3Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2Health News:Millennium Treatment Group Has a New Website 2Health News:Beat Eczema: Review Exposes Susan Clark’s Guide to Curing Eczema Naturally 2Health News:Deletion predicts survival in advanced non-small cell lung cancer 2
... Pharmacopeia,(Nasdaq: PCOP ), an innovator in ... today announced that it has licensed from,Bristol-Myers Squibb ... modulator,(SARM) program, including a lead compound in Phase ... non-steroidal selective androgen,receptor modulator, or SARM, which was ...
... Ill. A study published in the October ... (JCSM) finds that modafinil is well-tolerated in the treatment ... wakefulness such as shift work sleep disorder, obstructive sleep ... or sleep parameters. , The study, authored by Thomas ...
... 15 With school schedules now routine and,the initial ... again",sighs. This might be a good time to re-evaluate ... http://www.newscom.com/cgi-bin/prnh/20071015/NYFNSL01 ) The following are suggestions ... and snacks for greater nutritional impact. Add a,handful of ...
... - ,Real Women, Real Pain, Campaign Highlights ... in Women Around the World Today, the International ... the Global Year Against Pain in Women to draw ... and the need for more,effective care. Lack of awareness ...
... A new study by Rhode Island Hospital and Brown University ... surgery did not receive the initial psychiatric clearance for the ... of decisions to clear candidates for surgery, and the largest ... and detail the reasons for exclusion. It was published in ...
... Attention-deficit/hyperactivity disorder (ADHD), a state of serious impairments in ... many labels for one of the most prevalent conditions ... partly persists into adulthood. ADHD is conservatively estimated to ... 1998), but more permissive criteria yield estimates of up ...
Cached Medicine News:Health News:Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb 2Health News:Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb 3Health News:Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb 4Health News:Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb 5Health News:Study: Modafinil is effective in treating excessive sleepiness 2Health News:Fresh, Tasty - Healthy - Lunch and Snack Ideas 2Health News:International Association for the Study of Pain (IASP) Declares the Global Year Against Pain in Women 2Health News:International Association for the Study of Pain (IASP) Declares the Global Year Against Pain in Women 3Health News:1 in 5 bariatric surgery candidates not psychologically cleared for surgery 2Health News:Computerized training of working memory is a promising therapeutic strategy in ADHD 2Health News:Computerized training of working memory is a promising therapeutic strategy in ADHD 3
... Instruments were developed in surgeon's desire to ... having an instrument with the strength to ... of the bending or breaking. Arthrotek Hand ... conform to the surgeon's hand. This new ...
This optimal design addresses low-cost, simple, non-invasive ankle distraction....
... BTA stat Test is an ... qualitative detection of bladder tumor ... with bladder cancer. This test ... aid in the management of ...
... TheraTears Liquid Gel is a thicker version ... or for those who need a longer-lasting ... Liquid Gel is so long-lasting, it is ... preserved gels, there never needs to be ...
Medicine Products: